This is not the most recent version of the article. View current version (5 OCT 2011)

Intervention Review

Decision aids for people facing health treatment or screening decisions

  1. Annette M. O'Connor1,*,
  2. Carol L Bennett2,
  3. Dawn Stacey3,
  4. Michael Barry4,
  5. Nananda F Col5,
  6. Karen B Eden6,
  7. Vikki A Entwistle7,
  8. Valerie Fiset8,
  9. Margaret Holmes-Rovner9,
  10. Sara Khangura2,
  11. Hilary Llewellyn-Thomas10,
  12. David Rovner11

Editorial Group: Cochrane Consumers and Communication Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 30 JUN 2006

DOI: 10.1002/14651858.CD001431.pub2

How to Cite

O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD001431. DOI: 10.1002/14651858.CD001431.pub2.

Author Information

  1. 1

    Senior Scientist, Clinical Epidemiology Program, Ottawa Health Research Institute, Professor, School of Nursing, Department of Epidemiology, University of Ottawa, Ottawa, Ontario, Canada

  2. 2

    Ottawa Health Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada

  3. 3

    University of Ottawa, School of Nursing, Ottawa, Ontario, Canada

  4. 4

    Massachusetts General Hospital, General Medicine Unit, Boston, MA, USA

  5. 5

    Maine Medical Center, Center for Outcomes Research and Evaluation, Portland, ME, USA

  6. 6

    Oregon Health Sciences University, Department of Medical Informatics and Clinical Epidemiology, Portland, Oregon, USA

  7. 7

    University of Dundee, Social Dimensions of Health Institute, Dundee, UK

  8. 8

    Algonquin College, Nursing Program, Ottawa, Ontario, Canada

  9. 9

    Michigan State University College of Human Medicine, Center for Ethics and Humanities in the Life Sciences, East Lansing, Michigan, USA

  10. 10

    Dartmouth University, Center for the Evaluation of Clinical Sciences, Dartmouth Medical School, Hanover, New Hampshire, USA

  11. 11

    East Lansing, Michigan, USA

*Annette M. O'Connor, Professor, School of Nursing, Department of Epidemiology, University of Ottawa, Senior Scientist, Clinical Epidemiology Program, Ottawa Health Research Institute, 1053 Carling Avenue, (ASB 2-008), Ottawa, Ontario, K1Y 4E9, Canada. aoconnor@ohri.ca.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 8 JUL 2009

SEARCH

This is not the most recent version of the article.View current version (05 Oct 2011)

 

Abstract

  1. Top of page
  2. Abstract
  3. Plain language summary

Background

Decision aids prepare people to participate in 'close call' decisions that involve weighing benefits, harms, and scientific uncertainty.

Objectives

To conduct a systematic review of randomised controlled trials (RCTs) evaluating the efficacy of decision aids for people facing difficult treatment or screening decisions.

Search strategy

We searched MEDLINE (Ovid) (1966 to July 2006); Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library; 2006, Issue 2); CINAHL (Ovid) (1982 to July 2006); EMBASE (Ovid) (1980 to July 2006); and PsycINFO (Ovid) (1806 to July 2006). We contacted researchers active in the field up to December 2006. There were no language restrictions.

Selection criteria

We included published RCTs of interventions designed to aid patients' decision making by providing information about treatment or screening options and their associated outcomes, compared to no intervention, usual care, and alternate interventions. We excluded studies in which participants were not making an active treatment or screening decision, or if the study's intervention was not available to determine that it met the minimum criteria to qualify as a patient decision aid.

Data collection and analysis

Two review authors independently screened abstracts for inclusion, and extracted data from included studies using standardized forms. The primary outcomes focused on the effectiveness criteria of the International Patient Decision Aid Standards (IPDAS) Collaboration: attributes of the decision and attributes of the decision process. We considered other behavioural, health, and health system effects as secondary outcomes. We pooled results of RCTs using mean differences (MD) and relative risks (RR) using a random effects model.

Main results

This update added 25 new RCTs, bringing the total to 55. Thirty-eight (69%) used at least one measure that mapped onto an IPDAS effectiveness criterion: decision attributes: knowledge scores (27 trials); accurate risk perceptions (11 trials); and value congruence with chosen option (4 trials); and decision process attributes: feeling informed (15 trials) and feeling clear about values (13 trials).

This review confirmed the following findings from the previous (2003) review. Decision aids performed better than usual care interventions in terms of: a) greater knowledge (MD 15.2 out of 100; 95% CI 11.7 to 18.7); b) lower decisional conflict related to feeling uninformed (MD -8.3 of 100; 95% CI -11.9 to -4.8); c) lower decisional conflict related to feeling unclear about personal values (MD -6.4; 95% CI -10.0 to -2.7); d) reduced the proportion of people who were passive in decision making (RR 0.6; 95% CI 0.5 to 0.8); and e) reduced proportion of people who remained undecided post-intervention (RR 0.5; 95% CI 0.3 to 0.8). When simpler decision aids were compared to more detailed decision aids, the relative improvement was significant in knowledge (MD 4.6 out of 100; 95% CI 3.0 to 6.2) and there was some evidence of greater agreement between values and choice.

In this review, we were able to explore the use of probabilities in decision aids. Exposure to a decision aid with probabilities resulted in a higher proportion of people with accurate risk perceptions (RR 1.6; 95% CI 1.4 to 1.9). The effect was stronger when probabilities were measured quantitatively (RR 1.8; 95% CI 1.4 to 2.3) versus qualitatively (RR 1.3; 95% CI 1.1 to 1.5).

As in the previous review, exposure to decision aids continued to demonstrate reduced rates of: elective invasive surgery in favour of conservative options, decision aid versus usual care (RR 0.8; 95% CI 0.6 to 0.9); and use of menopausal hormones, detailed versus simple aid (RR 0.7; 95% CI 0.6 to 1.0). There is now evidence that exposure to decision aids results in reduced PSA screening, decision aid versus usual care (RR 0.8; 95% CI 0.7 to 1.0) . For other decisions, the effect on decisions remains variable.

As in the previous review, decision aids are no better than comparisons in affecting satisfaction with decision making, anxiety, and health outcomes. The effects of decision aids on other outcomes (patient-practitioner communication, consultation length, continuance, resource use) were inconclusive.

There were no trials evaluating the IPDAS decision process criteria relating to helping patients to recognize a decision needs to be made, understand that values affect the decision, or discuss values with the practitioner.

Authors' conclusions

Patient decision aids increase people's involvement and are more likely to lead to informed values-based decisions; however, the size of the effect varies across studies. Decision aids have a variable effect on decisions. They reduce the use of discretionary surgery without apparent adverse effects on health outcomes or satisfaction. The degree of detail patient decision aids require for positive effects on decision quality should be explored. The effects on continuance with chosen option, patient-practitioner communication, consultation length, and cost-effectiveness need further evaluation.

 

Plain language summary

  1. Top of page
  2. Abstract
  3. Plain language summary

Decision aids to help people who are facing health treatment or screening decisions

Making a decision about the best option to manage health can be difficult. Getting information on the options and the possible benefits and harms in the form of decision aids may help. Decision aids, such as pamphlets and videos that describe options, are designed to help people understand the options, consider the personal importance of possible benefits and harms, and participate in decision making. They are used when there is more than one medically reasonable option - no option has a clear advantage in terms of health outcomes, each has benefits and harms that people value differently. The updated review of trials found that decision aids improve people's knowledge of the options, create accurate risk perceptions of their benefits and harms, reduce difficulty with decision making, and increase participation in the process. They may have a role in preventing use of options that informed patients don't value without adversely affecting health outcomes. They did not seem to have an effect on satisfaction with decision making or anxiety.